Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Schneider Phillip M

SEC-identified person · CIK 1230051 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Silverback Therapeutics, Inc. SPRY Director filed 2022–2026
Longboard Pharmaceuticals, Inc. LBPH Director filed 2021–2024
Pfenex Inc. PFNX Director filed 2014–2020
Arena Pharmaceuticals INC ARNA Director filed 2007–2017
Auspex Pharmaceuticals, Inc. ASPX Director filed 2014–2015
GEN Probe INC GPRO Director filed 2006–2012
Micromet, INC. MITI Director filed 2006–2007

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.